Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 17, 2008 - Issue 5
Submit an article Journal homepage
196
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluation

Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens

Garyphallia Poulakou University General Hospital ATTIKON, National and Kapodistrian University of Athens Medical School, 4th Department of Internal Medicine, 1 Rimini street, 124 62 Athens, Greece +30 210 583 1990; +30 210 532 6446; [email protected]
, MD &
Helen Giamarellou University General Hospital ATTIKON, National and Kapodistrian University of Athens Medical School, 4th Department of Internal Medicine, 1 Rimini street, 124 62 Athens, Greece +30 210 583 1990; +30 210 532 6446; [email protected]
, MD PhD
Pages 749-771 | Published online: 30 Apr 2008

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

S. Shakil, M. Danishuddin & A.U. Khan. (2009) Doripenem Versus Bacteria: An Emerging Battleground. Journal of Chemotherapy 21:5, pages 482-492.
Read now
Tze Shien Lo, Stephanie M Borchardt, Justin M Welch, Melissa A Rohrich, Augusto M Alonto & Anne V Alonto. (2009) Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections. Infection and Drug Resistance 2, pages 41-49.
Read now

Articles from other publishers (14)

Donald J. AbrahamSebastian A. Testero, Leticia I. Llarrull, Jed F. Fisher & Shahriar Mobashery. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 188 .
Theodoros Karampatakis, Charalampos Antachopoulos, Athanassios Tsakris & Emmanuel Roilides. (2018) Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data. European Journal of Clinical Microbiology & Infectious Diseases 37:7, pages 1211-1220.
Crossref
James S. LewisIIII & Karen Bush. 2015. Manual of Clinical Microbiology . Manual of Clinical Microbiology 1169 1211 .
Garyphallia Poulakou, Matteo Bassetti, Elda Righi & George Dimopoulos. (2014) Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens. Future Microbiology 9:9, pages 1053-1069.
Crossref
Parikshit Singh, Rajshree Ramasethu & Amit Sharma. (2014) Prone ventilation and critical care management of severe ARDS and multiorgan failure in a young patient. Medical Journal Armed Forces India 70:1, pages 85-88.
Crossref
Joseph D. C. Yao & Robert C. MoelleringJr.Jr.. 2011. Manual of Clinical Microbiology. Manual of Clinical Microbiology 1041 1081 .
Donald J. AbrahamSebastian A. Testero, Jed F. Fisher & Shahriar Mobashery. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 257 402 .
María José Fresnadillo Martínez, María Inmaculada García García, Enrique García Sánchez & José Elías García Sánchez. (2010) Los carbapenems disponibles: Propiedades y diferencias. Enfermedades Infecciosas y Microbiología Clínica 28, pages 53-64.
Crossref
V. Cattoir & C. Daurel. (2010) Quelles nouveautés en antibiothérapie ?. Médecine et Maladies Infectieuses 40:3, pages 135-154.
Crossref
Kathryn A. Connor. (2010) New Intravenous Antibiotics. AACN Advanced Critical Care 21:3, pages 237-240.
Crossref
Helen Giamarellou & Garyphallia Poulakou. (2009) Multidrug-Resistant Gram-Negative Infections. Drugs 69:14, pages 1879-1901.
Crossref
Iolanda Cirillo, Nicole Vaccaro, Kenneth Turner, Bhavna Solanki, Jaya Natarajan & Rebecca Redman. (2009) Pharmacokinetics, Safety, and Tolerability of Doripenem After 0.5-, 1-, and 4-Hour Infusions in Healthy Volunteers. The Journal of Clinical Pharmacology 49:7, pages 798-806.
Crossref
Visanu Thamlikitkul & Suwanna Trakulsomboon. (2009) In Vitro Activity of Doripenem against Burkholderia pseudomallei . Antimicrobial Agents and Chemotherapy 53:7, pages 3115-3117.
Crossref
Spyros Pournaras, Elias Iosifidis & Emmanuel Roilides. (2009) Advances in Antibacterial Therapy Against Emerging Bacterial Pathogens. Seminars in Hematology 46:3, pages 198-211.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.